Morgan Stanley upgraded shares of Hikma Pharmaceutic (NASDAQ:HKMPF) from an equal rating to a weight rating in a research note published on Wednesday morning.

Hikma Pharmaceutic (NASDAQ:HKMPF) remained flat at $21.45 during trading on Wednesday. Hikma Pharmaceutic has a one year low of $20.50 and a one year high of $35.25. The firm has a market capitalization of $5146.88 billion and a price-to-earnings ratio of 26.22. The firm has a 50-day moving average price of $24.29 and a 200-day moving average price of $29.69.

5 Day Chart for NASDAQ:HKMPF

Receive News & Stock Ratings for Hikma Pharmaceutic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceutic and related stocks with our FREE daily email newsletter.